Pathological response and prognosis of stage III non-small cell lung cancer patients treated with induction chemoradiation-Reference-Cited by-同舟云学术

Pathological response and prognosis of stage III non-small cell lung cancer patients treated with induction chemoradiation

Published:2012-05-02 Issue:3 Volume:8 Page:260-266
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:

Author:

ISOBE Kazutoshi,HATA Yoshinobu,SAKAGUCHI Shinji,SATO Fumitomo,TAKAHASHI Shoji,SATO Keita,SANO Go,SUGINO Keishi,SAKAMOTO Susumu,TAKAI Yujiro,MITSUDA Aki,TERAHARA Atsuro,SHIBUYA Kazutoshi,TAKAGI Keigo,HOMMA Sakae

Publisher

Wiley

Subject

Oncology,General Medicine

Reference34 articles.

1. Revisions in the international system for staging lung cancer;Mountain;Chest,1997

2. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial;Dillman;J Natl Cancer Inst,1996

3. Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial;Stupp;Lancet Oncol,2009

4. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805;Albain;J Clin Oncol,1995

5. Advanced non-small cell lung cancer: induction chemotherapy and chemoradiation before operation;Cyjon;Ann Thorac Surg,2002

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative Predictive Factors for Tumor Regression and Survival in Non-Small Cell Lung Cancer Patients Undergoing Neoadjuvant Treatment and Lung Resection;Cancers;2024-08-20

2. Pathological response in resectable non–small cell lung cancer: a systematic literature review and meta-analysis;JNCI Cancer Spectrum;2024-03-23

3. Association of Pathologic Complete Response and Long-Term Survival Outcomes Among Patients Treated With Neoadjuvant Chemotherapy or Chemoradiotherapy for NSCLC: A Meta-Analysis;JTO Clinical and Research Reports;2022-09

4. Predictive factors of pathological complete response after induction (ypT0N0M0) in non-small cell lung cancer and short-term outcomes: Results of the Spanish Group of Video-assisted Thoracic Surgery (GE-VATS);Cirugía Española (English Edition);2022-06

5. CT-based radiomics signatures can predict the tumor response of non-small cell lung cancer patients treated with first-line chemotherapy and targeted therapy;European Radiology;2021-09-26